News Briefs: Agfa invests in RIS integration in Europe

Article

Agfa invests in RIS integration in EuropeAgfa Gevaert, headquartered in Mortsel, Belgium, signed a letter of intent to invest in Quadrat, a medical software company based in Deurle, Belgium. Terms of the agreement have not been disclosed; the deal

Agfa invests in RIS integration in Europe

Agfa Gevaert, headquartered in Mortsel, Belgium, signed a letter of intent to invest in Quadrat, a medical software company based in Deurle, Belgium. Terms of the agreement have not been disclosed; the deal is designed to broaden Agfa’s integrated PACS/RIS offerings in Europe. Agfa will provide Quadrat with the financial backing, sales and support teams, and customer base to market its RIS and electronic medical record (EMR) software. Quadrat plans to combine PACS and RIS on a single desktop, incorporating images into medAr, its multilingual EMR, which is distributed over the Internet.

In the U.S. market, Agfa plans a midyear launch for Embedded-IS, an option for Impax and Impax Basix that adds RIS functionality to their PACS product (PNN 1/00).

© 2000 Miller Freeman, Inc., a United News & Media company.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.